leflunomide has been researched along with Idiopathic Interstitial Pneumonia in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Leflunomide (LEF) is an isoxazole derivative used as disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA)." | 7.80 | [Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide]. ( Bartosiewicz, M; Bartoszuk, I; Jakubowska, L; Kuś, J; Siemion-Szcześniak, I; Wesołowski, S, 2014) |
| "Leflunomide (LEF) is an isoxazole derivative used as disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA)." | 3.80 | [Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide]. ( Bartosiewicz, M; Bartoszuk, I; Jakubowska, L; Kuś, J; Siemion-Szcześniak, I; Wesołowski, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siemion-Szcześniak, I | 1 |
| Bartoszuk, I | 1 |
| Bartosiewicz, M | 1 |
| Jakubowska, L | 1 |
| Wesołowski, S | 1 |
| Kuś, J | 1 |
1 other study available for leflunomide and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
[Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].
Topics: Acute Disease; Antirheumatic Agents; Arthritis, Rheumatoid; Glucocorticoids; Humans; Idiopathic Inte | 2014 |